Anixa Biosciences, Inc. a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced that, in conjunction with its partner...
InxMed Co., Ltd. announced that IN10018, its focal adhesion kinase (FAK) inhibitor, had been granted with Breakthrough Therapy Designation by the China National Medical...
The Association of Community Cancer Centers (ACCC) is pleased to announce a new suite of quality-directed resources for cancer programs, providers, and other stakeholders...
